Cite
MLA Citation
Adi Reches et al.. “Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity.” Journal for immunotherapy of cancer, vol. 8, no. 1, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127572798.0x000037